김중엽 (Harvard Medical School)님 | 한빛사연구자 > 한빛사

Harvard Medical School

CV File

최종업데이트 2025.07.23.

Anti-MSAD-1 humoral immunity: A novel biomarker in NTM-PD
- Am. J. Respir. Crit. Care Med., 10 February 2026 | https://doi.org/10.1093/ajrccm/aamag053
- 2026-02
- 의약학
- 한빛사논문
Gut-lung axis and microbiome alterations in mycobacterial infections: from pathogenesis to therapeutic potential
- Gut Microbes, 07 Jan 2026 | https://doi.org/10.1080/19490976.2025.2612428
- 2026-01
- 의약학
- 한빛사논문
Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: An individual patient data meta-analysis
- Eur. Resp. J., Jul 17 2025, 2500315 | https://doi.org/10.1183/13993003.00315-2025
- 2025-07
- 의약학
- 한빛사논문
Cytomegalovirus reactivation in the lower respiratory tract as an independent risk factor for mortality in critically Ill patients
- Crit. Care, May 02 2025, 29 (1) 177 | https://doi.org/10.1186/s13054-025-05324-8
- 2025-05
- 의약학
- 한빛사논문
Microbiological Cure at Treatment Completion Is Associated With Longer Survival in Patients With Mycobacterium avium Complex Pulmonary Disease
- Chest, Volume 164, Issue 5, November 2023, Pages 1108-1114 | https://doi.org/10.1016/j.chest.2023.06.015
- 2023-11
- 의약학
- 한빛사논문
Impact of treatment on long-term survival of patients with Mycobacterium avium complex pulmonary disease
- Clin. Infect. Dis., 2023 Mar 1;ciad108 | https://doi.org/10.1093/cid/ciad108
- 2023-03
- 의약학
- 한빛사논문
Outcomes of Adjunctive Surgery in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-analysis
- Chest, 2022 Oct 5;S0012-3692(22)03907-1 | doi: 10.1016/j.chest.2022.09.037
- 2022-10
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기